DYN
Price
$14.70
Change
+$0.71 (+5.08%)
Updated
Jun 6 closing price
Capitalization
1.59B
53 days until earnings call
IOBT
Price
$1.60
Change
+$0.10 (+6.67%)
Updated
Jun 6 closing price
Capitalization
98.49M
61 days until earnings call
Interact to see
Advertisement

DYN vs IOBT

Header iconDYN vs IOBT Comparison
Open Charts DYN vs IOBTBanner chart's image
Dyne Therapeutics
Price$14.70
Change+$0.71 (+5.08%)
Volume$2.67M
Capitalization1.59B
IO Biotech
Price$1.60
Change+$0.10 (+6.67%)
Volume$182.92K
Capitalization98.49M
DYN vs IOBT Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. IOBT commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and IOBT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (DYN: $11.76 vs. IOBT: $1.19)
Brand notoriety: DYN and IOBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 33% vs. IOBT: 101%
Market capitalization -- DYN: $1.59B vs. IOBT: $98.49M
DYN [@Biotechnology] is valued at $1.59B. IOBT’s [@Biotechnology] market capitalization is $98.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileIOBT’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • IOBT’s FA Score: 0 green, 5 red.
According to our system of comparison, IOBT is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while IOBT’s TA Score has 6 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • IOBT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IOBT is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а 0.00% price change this week, while IOBT (@Biotechnology) price change was +7.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

IOBT is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.59B) has a higher market cap than IOBT($98.5M). IOBT YTD gains are higher at: 29.348 vs. DYN (-50.085). IOBT has higher annual earnings (EBITDA): -89.37M vs. DYN (-342.21M). DYN has more cash in the bank: 642M vs. IOBT (80.2M). IOBT has less debt than DYN: IOBT (2.02M) vs DYN (24M). DYN (0) and IOBT (0) have equivalent revenues.
DYNIOBTDYN / IOBT
Capitalization1.59B98.5M1,615%
EBITDA-342.21M-89.37M383%
Gain YTD-50.08529.348-171%
P/E RatioN/AN/A-
Revenue00-
Total Cash642M80.2M800%
Total Debt24M2.02M1,189%
TECHNICAL ANALYSIS
Technical Analysis
DYNIOBT
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 12 days ago
86%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
88%
MACD
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 18 days ago
90%
Declines
ODDS (%)
Bearish Trend 26 days ago
89%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+0.51%
CRNX - DYN
53%
Loosely correlated
+1.39%
RNA - DYN
51%
Loosely correlated
+1.81%
ERAS - DYN
51%
Loosely correlated
+1.85%
KYMR - DYN
50%
Loosely correlated
+2.35%
XNCR - DYN
50%
Loosely correlated
-2.58%
More

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with GLMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
+4.39%
GLMD - IOBT
35%
Loosely correlated
-8.11%
DYN - IOBT
33%
Loosely correlated
+0.51%
TRDA - IOBT
29%
Poorly correlated
+0.91%
RGNX - IOBT
29%
Poorly correlated
-5.84%
IMUX - IOBT
28%
Poorly correlated
+2.27%
More